Subject(s)
Anesthesia, Local , Anxiety , Humans , Pilot Projects , Anxiety/etiology , Anxiety/prevention & control , Prospective Studies , CommunicationSubject(s)
Anesthesia, Local , Anxiety , Humans , Pilot Projects , Anxiety/etiology , Anxiety/prevention & control , Prospective Studies , CommunicationABSTRACT
We present a 30-year-old woman with a solitary circumscribed neuroma (also known as palisaded encapsulated neuroma) diagnosed after surgical excision. We describe the histopathologic correlation and the dermoscopic features we found in this tumor, which have not been previously reported in the literature to our knowledge.
Subject(s)
Neuroma/pathology , Skin Neoplasms/pathology , Adult , Cheek/pathology , Dermoscopy , Female , HumansABSTRACT
El uso de los láseres de colorante pulsado (pulse dye laser [PDL]) y de dióxido de carbono (CO2) para el tratamiento de los dermatofibromas (DF) ha demostrado tener buenos resultados clínicos. Un total de 23 DF fueron tratados en dos sesiones con el láser de alejandrita Q-Switched de 755 nm (7,5 J/cm2, 3 mm, 50 ms), dejando entre cada sesión un intervalo de 4semanas. Para el eritema residual se utilizó el láser V Beam PDL con una longitud de onda de 595nm (10-11 J/cm2, 7 mm, 1,5 ms). En 9 de las pacientes se observó una atenuación parcial de la coloración marrón y en 14 de ellas una desaparición completa de la misma. Las pacientes refirieron un grado elevado de satisfacción después de haber realizado el tratamiento. Así mismo, 15 de las pacientes notaron una disminución en el endurecimiento de los DF. En el examen dermatoscópico previo al tratamiento, en todos los DF se observó la presencia de una red de pigmento. Esta red de pigmento desapareció en todos los casos tras la aplicación del láser. La combinación del láser V Beam PDL y del láser de alejandrita Q-Switched en los DF constituye una alternativa terapéutica adecuada que, además de buenos resultados cosméticos, ha conseguido un elevado grado de satisfacción por parte de los pacientes
Pulsed dye and carbon dioxide lasers have been applied in dermatofibroma with clinical improvement. We treated 23 dermatofibromas two times at a 4-week interval with Q-Switched alexandrite laser 755 nm (7.5 J/cm2, 3 mm, 50 ms). V Beam pulsed dye laser with a wavelength of 595nm was used for the residual erythema (10-11 J/cm2, 7 mm, 1.5 ms). A partial attenuation of brown colour was observed in 9 patients and complete disappearance of brown colour in 14 patients. Patient satisfaction was very high. Fifteen patients felt a decrease in hardening of dermatofibroma after treatment. A pigment network in dermoscopy was observed in all patients before treatment and no one after treatment. A combined treatment using both V Beam pulsed dye laser and Q-Switched alexandrite laser may be a therapeutic option to reduce the aesthetic effect of dermatofibroma with a high patient satisfaction and good cosmetic outcomes
Subject(s)
Humans , Female , Adult , Middle Aged , Histiocytoma, Benign Fibrous/therapy , Lasers, Dye/therapeutic use , Intense Pulsed Light Therapy , Dermoscopy/methods , Lasers, Solid-State/therapeutic use , Prospective Studies , Patient Satisfaction , Hypopigmentation/diagnosisABSTRACT
Pulsed dye and carbon dioxide lasers have been applied in dermatofibroma with clinical improvement. We treated 23 dermatofibromas two times at a 4-week interval with Q-Switched alexandrite laser 755nm (7.5J/cm2, 3mm, 50ms). V Beam pulsed dye laser with a wavelength of 595nm was used for the residual erythema (10-11J/cm2, 7mm, 1.5ms). A partial attenuation of brown colour was observed in 9 patients and complete disappearance of brown colour in 14 patients. Patient satisfaction was very high. Fifteen patients felt a decrease in hardening of dermatofibroma after treatment. A pigment network in dermoscopy was observed in all patients before treatment and no one after treatment. A combined treatment using both V Beam pulsed dye laser and Q-Switched alexandrite laser may be a therapeutic option to reduce the aesthetic effect of dermatofibroma with a high patient satisfaction and good cosmetic outcomes.
Subject(s)
Histiocytoma, Benign Fibrous , Laser Therapy , Lasers, Dye , Lasers, Solid-State , Histiocytoma, Benign Fibrous/radiotherapy , Humans , Lasers, Dye/therapeutic use , Lasers, Solid-State/therapeutic use , Prospective StudiesABSTRACT
No disponible
Subject(s)
Humans , Male , Middle Aged , Lymphoma, Primary Cutaneous Anaplastic Large Cell/diagnosis , Lymphoma, Primary Cutaneous Anaplastic Large Cell/surgery , Fibroma/surgery , Papilloma/pathology , Papilloma/surgery , Skin Neoplasms/surgery , Back/pathology , Back/surgeryABSTRACT
No disponible
Subject(s)
Humans , Male , Adult , Molluscum Contagiosum/diagnosis , Molluscum Contagiosum/therapy , Cryotherapy/methods , Keratoderma, Palmoplantar/complications , Keratoderma, Palmoplantar/therapy , Diagnosis, DifferentialABSTRACT
La dermatología estética hoy en día contempla múltiples tratamientos mínimamente invasivos que pueden ayudar a envejecer a nuestros pacientes con elegancia y discreción. Dado que puede resultar difícil sistematizarlos para que el paciente sea consciente de las posibilidades que tiene en función del área que quiere mejorar, desde Clínica Dermatológica Internacional hemos elaborado el protocolo Skin Age Management (SAM). En este artículo describimos este protocolo -dirigido a ayudar a médicos y pacientes a conocer mejor y planificar los tratamientos disponibles, que refuerza el mensaje de la idoneidad de la combinación de técnicas con la filosofía de lograr cambios discretos para obtener los resultados que consideramos óptimos-, basado en la experiencia de nuestro centro
Aesthetic dermatology includes many minimally invasive therapies that can help our patients age gracefully and discreetly. Because it is hard to systematize these treatments to make patients aware of the options they have for the area of the face they want to improve, at Clínica Dermatológica Internacional, we have developed the Skin Age Management (SAM) protocol. In this article, we describe the protocol, which is aimed at helping doctors and patients to better understand and plan available treatments, underlining the advisability of combining techniques with the goal of achieving discreet changes to obtain what we consider to be optimum results, based on our experience at our center
Subject(s)
Humans , Skin Aging/drug effects , Rejuvenation , Botulinum Toxins, Type A , Hyaluronic Acid , Durapatite , 35170ABSTRACT
Aesthetic dermatology includes many minimally invasive therapies that can help our patients age gracefully and discreetly. Because it is hard to systematize these treatments to make patients aware of the options they have for the area of the face they want to improve, at Clínica Dermatológica Internacional, we have developed the Skin Age Management (SAM) protocol. In this article, we describe the protocol, which is aimed at helping doctors and patients to better understand and plan available treatments, underlining the advisability of combining techniques with the goal of achieving discreet changes to obtain what we consider to be optimum results, based on our experience at our center.
Subject(s)
Cosmetic Techniques , Rejuvenation , Skin Aging , HumansSubject(s)
Infarction/pathology , Polyps/pathology , Skin Diseases/pathology , Humans , Male , Middle Aged , Skin/blood supplyABSTRACT
La hiperhidrosis axilar (HA) y la bromhidrosis son un motivo de consulta frecuente en dermatología. Hoy en día el tratamiento más indicado es la inyección de toxina botulínica, una opción muy eficaz pero con el inconveniente de su temporalidad, y en el caso de la bromhidrosis su nula eficacia. Por otra parte, la indicación de la simpatectomía cada vez se recomienda menos por la alta incidencia de hiperhidrosis compensatoria. En este artículo se expone el tratamiento de la HA y la bromhidrosis con un dispositivo novedoso de microondas, capaz de reemplazar las glándulas ecrinas y apocrinas por fibrosis, consiguiendo unos resultados posiblemente permanentes. El procedimiento debe realizarse preferiblemente con anestesia local tumescente. Los efectos secundarios son temporales, principalmente inflamación local. Su eficacia clínica y seguridad sitúan a esta técnica, avalada por estudios recientes publicados, como una alternativa de primera elección tanto para la HA como para la bromhidrosis (AU)
Axillary hyperhidrosis (AH) and bromhidrosis are common causes of consultation in dermatology. Currently, the most widely prescribed treatment for AH is botulinum toxin, a very effective but temporary option; it is totally ineffective in bromhidrosis. Sympathectomy is an increasingly infrequent choice of treatment due to the high incidence of compensatory hyperhidrosis. We describe the treatment of AH and bromhidrosis with a novel microwave device that can fibrose eccrine and apocrine glands, achieving possibly permanent results. The procedure should preferably be performed under tumescent anesthesia. Side effects, principally local inflammation, are transient. Clinical effectiveness and safety, supported by recently published studies, position this technique as a first-choice option both for hyperhidrosis and for bromhidrosis (AU)
Subject(s)
Humans , Microwaves/therapeutic use , Hyperhidrosis/therapy , Sweat Gland Diseases/therapy , Botulinum Toxins, Type A/therapeutic use , SympathectomyABSTRACT
Axillary hyperhidrosis (AH) and bromhidrosis are common causes of consultation in dermatology. Currently, the most widely prescribed treatment for AH is botulinum toxin, a very effective but temporary option; it is totally ineffective in bromhidrosis. Sympathectomy is an increasingly infrequent choice of treatment due to the high incidence of compensatory hyperhidrosis. We describe the treatment of AH and bromhidrosis with a novel microwave device that can fibrose eccrine and apocrine glands, achieving possibly permanent results. The procedure should preferably be performed under tumescent anesthesia. Side effects, principally local inflammation, are transient. Clinical effectiveness and safety, supported by recently published studies, position this technique as a first-choice option both for hyperhidrosis and for bromhidrosis.
Subject(s)
Diathermy/methods , Hyperhidrosis/therapy , Microwaves/therapeutic use , Sweat Glands/radiation effects , Anesthesia, Local/methods , Diathermy/adverse effects , Diathermy/economics , Diathermy/instrumentation , Fibrosis , Humans , Multicenter Studies as Topic , Odorants , Randomized Controlled Trials as Topic , Retrospective Studies , Sweat Glands/pathology , Sweating/radiation effects , Treatment OutcomeABSTRACT
La toxina botulínica es la técnica estética más realizada en Estados Unidos, y en los últimos años se ha convertido, junto con los rellenos, en el eje de la prevención y el tratamiento del envejecimiento facial. Sin embargo, hay ocasiones en que se obtienen resultados poco naturales, bien debido a una inhibición marcada de la expresión, bien por determinados signos que «delatan» que una persona ha sido infiltrada. En este artículo revisamos los 10 errores que han de evitarse cuando se infiltra toxina botulínica. Adicionalmente, reflexionamos sobre la influencia de la toxina botulínica a través de nuestra gesticulación, tanto en lo que sentimos como en lo que sienten los demás
Injection of botulinum toxin is currently the most common cosmetic procedure in the United States, and in recent years it has become-together with dermal fillers-the mainstay of therapy for the prevention and treatment of facial aging. However, in some cases the treatment may lead to a somewhat unnatural appearance, usually caused by loss of facial expression or other telltale signs. In the present article, we review the 10 mistakes that should be avoided when injecting botulinum toxin. We also reflect on how treatment with botulinum toxin influences us through our facial expressions, both in terms of how we feel and what others perceive